Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion

被引:33
作者
Dash, BC
Harikrishnan, TA
Goila, R
Shahi, S
Unwalla, H
Husain, S
Banerjea, AC
机构
[1] Natl Inst Immunol, Virol Lab, New Delhi 110067, India
[2] Univ Minnesota, Minneapolis, MN 55455 USA
[3] Guru Nanak Dev Univ, Dept Microbiol, Amritsar, Punjab, India
关键词
DNA enzyme; HIV-1 Env gene; cell membrane fusion; syncytia;
D O I
10.1016/S0014-5793(98)00799-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the ultimate aim of developing an effective antiviral strategy against HIV-1, a mono-DNA enzyme possessing the 10-23 catalytic motif [Santoro and Joyce (1997) Proc, Natl, Acad, Sci, USA 94, 4264-4266] was synthesized against the HIV-1 envelope gene. We tested the in vitro cleavage efficiency of the 178 bp long truncated HIV-I Env transcript by DNA enzyme 6339. Protein independent and Mg2+ dependent specific cleavage products were obtained. As soon as 5 min after mixing equimolar concentrations of DNA enzyme and substrate RNA, more than 50% cleavage was observed which increased steadily over a period of 4 h. Very little cleavage was obtained at 1 mM MgCl2 concentration which improved significantly when the concentration of MgCl2 was increased up to 20 mM, Specific inhibition of cell membrane fusion caused by the interaction of gp160 and CD4 in HeLa cells was observed when the above DNA enzyme was used. Thus, these chemically synthesized DNA enzymes could prove to be very useful for in vivo application, (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 28 条
  • [11] USE OF A HYBRID VACCINIA VIRUS-T7 RNA-POLYMERASE SYSTEM FOR EXPRESSION OF TARGET GENES
    FUERST, TR
    EARL, PL
    MOSS, B
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (07) : 2538 - 2544
  • [12] SIMPLE RNA ENZYMES WITH NEW AND HIGHLY SPECIFIC ENDORIBONUCLEASE ACTIVITIES
    HASELOFF, J
    GERLACH, WL
    [J]. NATURE, 1988, 334 (6183) : 585 - 591
  • [13] Husain S, 1998, J Hum Virol, V1, P187
  • [14] First report of a healthy Indian heterozygous for Δ32 mutant of HIV-1 co-receptor-CCR5 gene
    Husain, S
    Goila, R
    Shahi, S
    Banerjea, AC
    [J]. GENE, 1998, 207 (02) : 141 - 147
  • [15] PURIFICATION OF FOUR STRAINS OF POXVIRUS
    JOKLIK, WK
    [J]. VIROLOGY, 1962, 18 (01) : 9 - &
  • [16] A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function
    Kumar, V
    Jayasuryan, N
    Kumar, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) : 5647 - 5652
  • [17] Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA
    Kuwabara, T
    Warashina, M
    Tanabe, T
    Tani, K
    Asano, S
    Taira, K
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (15) : 3074 - 3081
  • [18] INHIBITION OF REPLICATION OF HIV-1 BY RETROVIRAL VECTORS EXPRESSING TAT-ANTISENSE AND ANTI-TAT RIBOZYME RNA
    LO, KMS
    BIASOLO, MA
    DEHNI, G
    PALU, G
    HASELTINE, WA
    [J]. VIROLOGY, 1992, 190 (01) : 176 - 183
  • [19] Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis
    Paik, SY
    Banerjea, A
    Chen, CJ
    Ye, ZP
    Harmison, GG
    Schubert, M
    [J]. HUMAN GENE THERAPY, 1997, 8 (09) : 1115 - 1124
  • [20] INDUCIBLE AND CONDITIONAL INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS PROVIRAL EXPRESSION BY VESICULAR STOMATITIS-VIRUS MATRIX PROTEIN
    PAIK, SY
    BANERJEA, AC
    HARMISON, GG
    CHEN, CJ
    SCHUBERT, M
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3529 - 3537